Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana

Abstract

The ever-growing commercialization of poor-quality and substandard medicines, especially anti-infectives characterized by inadequate postmarket surveillance by stakeholders remains a major global health challenge, particularly in developing countries, where antibiotic drug resistance and its repercussions on human health remain dominant. This research sought to evaluate the pharmaceutical quality of six randomly selected brands of cefuroxime axetil tablets (250 mg) marketed in the Greater Accra region of Ghana. The selected brands were coded and subjected to both compendial and noncompendial tests. Statistical analysis and model-independent parameter (similarity factor, f2) were employed in analyzing the dissolution profiles of all the brands. All brands including the reference brand conformed to the pharmacopeial specifications for both compendial and noncompendial tests, indicating that they were of good quality. However, there were significant variations ( p < 0.05 ) in the disintegration time amongst the various brands. All the brands had ƒ2 values > 50 indicating similarity of their drug release profiles with the innovator. Hence, all the sampled cefuroxime axetil brands can be considered as pharmaceutical equivalents to the innovator drug. These brands can, therefore, be used as a substitute for the innovator drug by physicians to patients in cases of unaffordability or unavailability of the innovator brand.

In vitro Comparative Quality Assessment of Different Brands of Hydrochlorothiazide Tablets Marketed in Northeast Ethiopia

“…Regardless of addressing medical products to the community, there are still unethical commercial practices that influence the service quality by manufacturing and distributing poor-quality medication into the market 32 . Therefore, ensuring the quality of medication that are available in the market could be a primary step for controlling the disease condition and decreasing the circulation of poor-quality medication in the supply chain.…”

Development and In Vitro Evaluation of Oral Capsules from Antiaris: A Convenient Substitute for Peripheral Neuropathy

“…The difference ( f1 ) and similarity factors ( f2 ) for the dissolution profile of the decoction (aqueous extract) as compared to the release of the extract from formulations A01, A02, A03, and A04 were determined using the model independent approach. where n is the time points, Rt is the cumulative percentage dissolved at time t for the reference, and Tt is the cumulative percentage dissolved at time t for the test [ 17 ]…”

Challenges in the distribution of antimicrobial medications in community dispensaries in Accra, Ghana

“…Imported medicines were, however, typically more expensive and could sometimes be more difficult to procure. Lower-cost local brands may have been more accessible and could match their efficacy, though there was limited infrastructure in place to guarantee their quality [83][84][85][86][87]. Some shopkeepers may have been interested in relevant government bodies supporting improved procurement and quality monitoring, in order to offer effective medications at prices their customers could afford.…”